Impact of the microbiome on checkpoint inhibitor treatment in patients with non-small cell lung cancer and melanoma

by Fyza Y. Shaikh, Joell J. Gills, Cynthia L. Sears
Published 2019-10-01

Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance.

by Chunyu Zhang, Abdel G Elkahloun, Matthew Robertson, Joell J Gills, Junji Tsurutani, Joanna H Shih, Junya Fukuoka, M Christine Hollander, Curtis C Harris, William D Travis, Jin Jen, Phillip A Dennis
Published 2011-01-01